Pioneering Medicines 02, LLC - 02 Mar 2026 Form 3 Insider Report for Generate Biomedicines, Inc. (GENB)

Role
10%+ Owner
Signature
Pioneering Medicines 02, LLC, By: /s/ Charles R. Carelli, Jr., Manager
Issuer symbol
GENB
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
3
Filing time
12 Mar 2026, 17:00:03 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pioneering Medicines 02, LLC 10%+ Owner 55 CAMBRIDGE PARKWAY,, SUITE 800E, CAMBRIDGE Pioneering Medicines 02, LLC, By: /s/ Charles R. Carelli, Jr., Manager 12 Mar 2026 0002117576

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GENB Common Stock 1,562,500 02 Mar 2026 By Pioneering Medicines 02, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held by Pioneering Medicines 02, LLC ("PM02"). Charles R. Carelli, Jr., Chief Financial Officer of Flagship Pioneering, LLC ("Flagship Pioneering"), is the sole manager of PM02, and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") is its majority equity holder. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the ultimate control person of Flagship Pioneering. The Reporting Person disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any.